Protection against H5N1 highly pathogenic avian and pandemic (H1N1) 2009 influenza virus infection in cynomolgus monkeys by an inactivated H5N1 whole particle vaccine

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Nakayama, Misako ^a   Shichinohe, Shintaro ^b   Itoh, Yasushi ^a   Ishigaki, Hirohito ^a   Kitano, Mitsutaka ^a   Arikata, Masahiko ^a   Pham, Van Loi ^a   Ishida, Hideaki ^a   Kitagawa, Naoko ^a   Okamatsu, Masatoshi ^b   Sakoda, Yoshihiro ^b   Ichikawa, Takaya ^b   Tsuchiya, Hideaki ^a   Nakamura, Shinichiro ^a   Le, Quynh Mai ^d   Ito, Mutsumi ^e   Kawaoka, Yoshihiro ^e,f   Kida, Hiroshi ^b,c   Ogasawara, Kazumasa ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^e UNIVERSITY OF TOKYO   (Japan)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GAMMA INTERFERON; HEMAGGLUTININ ANTIBODY; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; UNCLASSIFIED DRUG; INACTIVATED VACCINE; SIALIDASE; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CLADISTICS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG POTENCY; FEMALE; FLOW CYTOMETRY; HUMORAL IMMUNITY; INFLUENZA A (H5N1); MACACA FASCICULARIS; MORBIDITY; NONHUMAN; VIRUS IMMUNITY; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS PARTICLE; ANIMAL; ANTAGONISTS AND INHIBITORS; ANTIBODY PRODUCTION; BIRD; BODY TEMPERATURE; HUMAN; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; INFLUENZA, HUMAN; METABOLISM; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMIC; PATHOGENICITY; SERODIAGNOSIS; T LYMPHOCYTE; VACCINATION; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; BIRDS; BODY TEMPERATURE; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MACACA FASCICULARIS; NEURAMINIDASE; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS; T-LYMPHOCYTES; VACCINATION; VACCINES, INACTIVATED; VIRAL LOAD;

EID: 84893507813     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082740     Document Type: Article

References (43)

1. Sugita S, Yoshioka Y, Itamura S, Kanegae Y, Oguchi K, et al. (1991) Molecular evolution of hemagglutinin genes of H1N1 swine and human influenza A viruses. J Mol Evol 32: 16-23.
2. Nidom CA, Takano R, Yamada S, Sakai-Tagawa Y, Daulay S, et al. (2010) Influenza A (H5N1) viruses from pigs, Indonesia. Emerg Infect Dis 16: 1515-1523.
3. Kida H, Shortridge KF, Webster RG (1988) Origin of the hemagglutinin gene of H3N2 influenza viruses from pigs in China. Virology 162: 160-166.
4. Yasuda J, Shortridge KF, Shimizu Y, Kida H (1991) Molecular evidence for a role of domestic ducks in the introduction of avian H3 influenza viruses to pigs in southern China, where the A/Hong Kong/68 (H3N2) strain emerged. J Gen Virol 72 (Pt 8): 2007-2010.
5. Neumann G, Noda T, Kawaoka Y (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939.
6. Kida H, Kawaoka Y, Naeve CW, Webster RG (1987) Antigenic and genetic conservation of H3 influenza virus in wild ducks. Virology 159: 109-119.
7. WHO/OIE/FAO H5N1 Evolution Working Group (2012) Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature. Influenza Other Respi Viruses 6: 1-5.
8. Sakoda Y, Ito H, Uchida Y, Okamatsu M, Yamamoto N, et al. (2012) Reintroduction of H5N1 highly pathogenic avian influenza virus by migratory water birds, causing poultry outbreaks in the 2010-2011 winter season in Japan. J Gen Virol 93: 541-550.
9. Murakami S, Iwasa A, Iwatsuki-Horimoto K, Ito M, Kiso M, et al. (2008) Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model. Vaccine 26: 6398-6404.
10. Kida H, Sakoda Y (2006) Library of influenza virus strains for vaccine and diagnostic use against highly pathogenic avian influenza and human pandemics. Dev Biol (Basel) 124: 69-72. (Pubitemid 43258901)
11. Itoh Y, Ozaki H, Tsuchiya H, Okamoto K, Torii R, et al. (2008) A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. Vaccine 26: 562-572.
12. Itoh Y, Ozaki H, Ishigaki H, Sakoda Y, Nagata T, et al. (2010) Subcutaneous inoculation of a whole virus particle vaccine prepared from a non-pathogenic virus library induces protective immunity against H7N7 highly pathogenic avian influenza virus in cynomolgus macaques. Vaccine 28: 780-789.
13. Arikata M, Itoh Y, Okamatsu M, Maeda T, Shiina T, et al. (2012) Memory immune responses against pandemic (H1N1) 2009 influenza virus induced by a whole particle vaccine in cynomolgus monkeys carrying Mafa-A1*052:02. PLoS One 7: e37220.
14. Soda K, Sakoda Y, Isoda N, Kajihara M, Haraguchi Y, et al. (2008) Development of vaccine strains of H5 and H7 influenza viruses. Jpn J Vet Res 55: 93-98. (Pubitemid 351325956)
15. Shichinohe S, Okamatsu M, Yamamoto N, Noda Y, Nomoto Y, et al. (2013) Potency of an inactivated influenza vaccine prepared from a non-pathogenic H5N1 virus against a challenge with antigenically drifted highly pathogenic avian influenza viruses in chickens. Vet Microbiol 164: 39-45.
16. Miyake T, Soda K, Itoh Y, Sakoda Y, Ishigaki H, et al. (2010) Amelioration of pneumonia with Streptococcus pneumoniae infection by inoculation with a vaccine against highly pathogenic avian influenza virus in a non-human primate mixed infection model. J Med Primatol 39: 58-70.
17. Pham VL, Nakayama M, Itoh Y, Ishigaki H, Kitano M, et al. (2013) Pathogenicity of pandemic H1N1 influenza A virus in immunocompromised cynomolgus macaques. PLoS One 8: e75910.
18. Virelizier JL (1975) Host defenses against influenza virus: the role of anti-hemagglutinin antibody. J Immunol 115: 434-439.
19. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, et al. (2009) Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A 106: 3455-3460.
20. Yang P, Tang C, Luo D, Zhan Z, Xing L, et al. (2010) Cross-clade protection against HPAI H5N1 influenza virus challenge in BALB/c mice intranasally administered adjuvant-combined influenza vaccine. Vet Microbiol 146: 17-23.
21. Harada Y, Ninomiya-Mori A, Takahashi Y, Shirakura M, Kishida N, et al. (2011) Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice. Vaccine 29: 8330-8337.
22. Baras B, Stittelaar KJ, Simon JH, Thoolen RJ, Mossman SP, et al. (2008) Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine. PLoS One 3: e1401.
23. Gustin KM, Maines TR, Belser JA, van Hoeven N, Lu X, et al. (2011) Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets. J Infect Dis 204: 1491-1499.
24. Schwartz JA, Buonocore L, Suguitan A Jr, Hunter M, Marx PA, et al. (2011) Vesicular stomatitis virus-based H5N1 avian influenza vaccines induce potent cross-clade neutralizing antibodies in rhesus macaques. J Virol 85: 4602-4605.
25. Ehrlich HJ, Muller M, Oh HM, Tambyah PA, Joukhadar C, et al. (2008) A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N Engl J Med 358: 2573-2584. (Pubitemid 351831358)
26. Crowe BA, Bruhl P, Gerencer M, Schwendinger MG, Pilz A, et al. (2010) Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans. Vaccine 29: 166-173.
27. Couch RB, Kasel JA (1983) Immunity to influenza in man. Annu Rev Microbiol 37: 529-549.
28. Tamura S, Tanimoto T, Kurata T (2005) Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines. Jpn J Infect Dis 58: 195-207. (Pubitemid 41460922)
29. McMichael AJ, Gotch FM, Noble GR, Beare PA (1983) Cytotoxic T-cell immunity to influenza. N Engl J Med 309: 13-17. (Pubitemid 13062888)
30. Bethell D, Saunders D, Jongkaewwattana A, Kramyu J, Thitithayanont A, et al. (2013) Evaluation of in vitro cross-reactivity to avian H5N1 and pandemic H1N1 2009 influenza following prime boost regimens of seasonal influenza vaccination in healthy human subjects: a randomised trial. PLoS One 8: e59674.
31. Marcelin G, DuBois R, Rubrum A, Russell CJ, McElhaney JE, et al. (2011) A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus. PLoS One 6: e26335.
32. Wan H, Gao J, Xu K, Chen H, Couzens LK, et al. (2013) Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses. J Virol 87: 9290-9300.
33. +T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol 159: 5197-5200.
34. +T cells correlate with disease protection against influenza challenge in humans. Nat Med 18: 274-280.
35. Nguyen HH, van Ginkel FW, Vu HL, McGhee JR, Mestecky J (2001) Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes. J Infect Dis 183: 368-376. (Pubitemid 32105595)
36. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021-1025.
37. Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, et al. (2004) Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 350: 1179-1188.
38. Le QM, Ito M, Muramoto Y, Hoang PV, Vuong CD, et al. (2010) Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans between 2003 and 2008 in northern Vietnam. J Gen Virol 91: 2485-2490.
39. Okamatsu M, Tanaka T, Yamamoto N, Sakoda Y, Sasaki T, et al. (2010) Antigenic, genetic, and pathogenic characterization of H5N1 highly pathogenic avian influenza viruses isolated from dead whooper swans (Cygnus cygnus) found in northern Japan in 2008. Virus Genes 41: 351-357.
40. Shiino T, Okabe N, Yasui Y, Sunagawa T, Ujike M, et al. (2010) Molecular evolutionary analysis of the influenza A(H1N1)pdm, May-September, 2009: temporal and spatial spreading profile of the viruses in Japan. PLoS One 5: e11057.
41. Kida H, Webster RG, Yanagawa R (1983) Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus. Arch Virol 76: 91-99. (Pubitemid 13025792)
42. Fujimoto K, Terato K, Miyamoto J, Ishiko H, Fujisaki M, et al. (1990) Establishment of a B-lymphoblastoid cell line infected with Epstein-Barr-related virus from a cynomolgus monkey (Macaca fascicularis). J Med Primatol 19: 21-30. (Pubitemid 20266206)
43. Hayashi K, Jin Z, Onoda S, Joko H, Teramoto N, et al. (2003) Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS. Am J Pathol 162: 1721-1736. (Pubitemid 36512855)